Study details
Enrolling now
Fluorescent Intra-operative Tumor Margin Examination
Kurt Weiss
NCT IDNCT04719156ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
110
Study length
about 4.8 years
Ages
18–100
Locations
1 site in PA
What this study is about
This trial is testing a new way to check if cancer has spread after surgery. It involves using a special dye and imaging device during the operation to see if there's any remaining tumor near the edge of the removed tissue. The goal is to improve how accurately we can identify and remove all cancerous cells.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Indocyanine green solution administered at 2.0mg/kg
- 2.Use Stryker SPY-PHI Imaging Device
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Devices
diagnostic